Linked EMR + Claims Data for Stronger HEOR Evidence

Manufacturers know that evidence is currency in payer negotiations. Fragmented datasets only tell a partial story that leaves payers skeptical. That’s why linked datasets have become the gold standard for health economics and outcomes research (HEOR). EMRClaims+ from...

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Launch plans rarely survive first contact with payers. One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access. Then they tested it with MAVA®. Launch...